Amplex Bids $100 Million to Acquire and Delist Addvise Group
Photo by Vitaly Gariev on Unsplash
Swedish investment firm Amplex launched a SEK 1.05 billion public takeover bid for life science company Addvise Group, aiming to delist it from the stock exchange, according to Medtech Magazine. Amplex's offer, at SEK 1.65 per share and SEK 0.49 per warrant, signifies a 42% premium over Addvise's recent valuation.
Key takeaways
- Amplex, a Swedish investment firm, has initiated a public takeover bid for Addvise Group, a life science company, valuing the firm at SEK 1
- Reported in Medtech Magazine by DI, the proposed acquisition includes a plan to delist Addvise from the stock exchange
- Amplex's offer of SEK 1
Related Topics
Want coverage like this for your company?
Local & industry wins build trusted proof, SEO/geo signals and prime national editors.
Check fit (2 min)Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Want to turn mentions into momentum? Find your best path with the Fit Checker. Verified profiles receive a free consult.